Dr. James W. Choi, MD

Dr. Choi practices at Dallas Surgi Center in Dallas, Texas.

Dr. Choi's NPI, 1497729123, was assigned on February 17, 2006. Dr. Choi graduated from Feinberg School of Medicine in 1997. Dr. Choi holds Texas license L8649.

Dr. Choi's primary practice is Dallas Surgi Center, at 8230 Walnut Hill Ln Suite 808, Dallas, TX 75231. The practice phone is (214) 696-8829.

Dr. Choi's primary practice is Dallas Surgi Center in Dallas, Texas. Dr. Choi is also affiliated with Texas Health Dallas. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Choi to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choi practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Choi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Choi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Choi's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Choi treats.

CMS data shows 1,653 Medicare services from Dr. Choi across 26 procedure codes in 2024, for 347 Medicare patients. Medicare paid $138,745 for them.

CMS counts 347 Medicare patients who saw Dr. Choi in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Choi's median patient age at 70, with 42% women.

In 2024, Dr. Choi wrote 3,784 Medicare Part D claims for 466 patients. 90% of them were for generic drugs. CMS names the drug for 3,617 of them, across 33 drugs with 11 or more claims each, at $413,534 in total drug cost. In 2023, CMS named 2,349 claims across 26 drugs.

Dr. Choi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Choi as offering telehealth. CMS counts 70 procedures of coronary angioplasty and stenting by Dr. Choi, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 147 papers to Dr. Choi, published from 2011 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Percutaneous Coronary Intervention, Coronary Occlusion and Coronary Angiography. Dr. Choi has published most often in J Invasive Cardiol. Dr. Choi's most frequent co-authors are Khaldoon Alaswad, MD, Jaikirshan J. Khatri, MD and Wissam A. Jaber, MD.

Dmand AI links Dr. Choi to 9 clinical trials. 4 are still active or recruiting. Conditions studied include Coronary Artery Disease, Hypertension and Coronary Disease. Abbott Medical Devices sponsors the most, 4.

CMS Open Payments shows 1,205 general payments to Dr. Choi from 52 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 34% of the total. ShockWave Medical, Inc paid the most, $116,835. It also lists 1 research payment totaling $19 in 2023.

Dmand AI lists 1 award for Dr. Choi.

Dr. Choi graduated from Feinberg School of Medicine in 1997. Dr. Choi is a member of ACC and SCAI.

Dr. Choi is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.